SCHEMBL5401409

SCHEMBL5401409

Clc1cccc(Br)c1Cl.[MgH2]

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
PNMT P11086 2/20 0.42
CYP1A2 P05177 3/20 0.41
CYP2A6 P11509 2/20 0.41
LMNA P02545 2/20 0.40
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
NFKB1 P19838 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
IDO1 P14902 2/20 0.37
ALDH1A1 P00352 2/20 0.37
GLA P06280 1/20 0.37
ERCC5 P28715 1/20 0.35
FEN1 P39748 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29387154 0.97
SCHEMBL221096 0.97
Ethylene SCHEMBL28130432 0.92 TSHR (0.44) TSHRPNMTCYP1A2CYP2A6LMNA
SCHEMBL2783652 0.82
Potassium SCHEMBL30965126 0.79 PDPK1 (0.38) TSHRPNMTCYP1A2CYP2A6LMNA
SCHEMBL29234423 0.79 PDPK1 (0.38) TSHRPNMTCYP1A2CYP2A6LMNA
SCHEMBL1005643 0.77
SCHEMBL2348739 0.77
SCHEMBL29363347 0.77
SCHEMBL28356286 0.75 HSD11B1 (0.46) TSHRCYP2A6LMNAIDO1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US disclosed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives CNR2, CNR1, HNMT TSHR 3507/4885PNMT 4/4885CYP1A2 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.